Skip to main content


Fig. 1 | BMC Complementary and Alternative Medicine

Fig. 1

From: In vitro assessment of hepatoprotective agents against damage induced by acetaminophen and CCl4

Fig. 1

Time-dependent changes in HepG2 cells. a Cell viability, b AST, c LDH, d ALT, e TAOxC, f SOD, g GSH, and h MDA levels after exposure to 20, 30, or 40 mM CCl4. Control: DMSO (0.05% v/v) in supplemented DMEMA; CCl4 20 mM: 1.92 μL of CCl4/DMSO (0.05% v/v) in supplemented DMEMA; CCl4 30 mM: 2.88 μL of CCl4/DMSO (0.05% v/v) in supplemented DMEMA; CCl4 40 mM: 3.84 μL of CCl4/DMSO (0.05% v/v) in supplemented DMEMA. Values are the mean ± SD of three independent experiments performed in triplicate. a P <0.05 vs C; b P <0.01 vs C

Back to article page